Autoimmune Disease Diagnosis Market - Global Forecast to 2022

Dublin, March 06, 2018 -- The "Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%.

The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market.

The global market is segmented by product and service, test type, disease, end user, and regions. By product and service, the global market is segmented into consumables and assay kits, instruments, and service. The consumables and assay kits segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the increasing adoption of consumables and assay kits and bulk buying of these products.

By test type, the market is classified into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory tests segment is estimated to account for the largest share of the global autoimmune disease diagnosis market during the next five years. Increasing adoption of routine tests in the diagnosis of chronic disease is very high which is driving the growth of this market.

By disease, the market is classified systemic lupus erythematosus, rheumatoid arthritis, Sjgren's syndrome, thyroiditis, scleroderma, and other diseases. In 2017, the rheumatoid arthritis segment is estimated to account for the largest share of the global market. The growth of this segment is mainly driven by the increasing incidences of the disease.

On the basis of end user, the autoimmune disease market is segmented into clinical laboratories, hospitals, and other end users. In 2017, the clinical laboratories segment is estimated to account for the largest share of the global market. Growth in the number of clinical laboratories coupled with better accessibility and availability of instruments are major factors driving the growth of this end-user segment.

The global autoimmune disease diagnosis market is dominated by North America, followed by Asia. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

The factors such as high degree of consolidation, high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth.

Major industry players launched innovative products to maintain and improve their position in the autoimmune disease diagnosis market. Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), HYCOR Biomedical (US), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (US), and Abbott Laboratories (US) have been identified as the key players in this market.

These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

Market Dynamics

Drivers

• High Incidence and Large Economic Burden of Autoimmune Diseases
• Increasing Access to Medical Insurance in the US

Restraints

• High Capital Requirements

Opportunities

• Growth Opportunities in Emerging Countries
• Increasing Number of Awareness Programs for Autoimmune Diseases

Trends

• Growth in the Number of Reagent Rental Agreements

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Autoimmune Disease Diagnosis Market, By Product & Service

7 Autoimmune Disease Diagnosis Market, By Test Type

8 Autoimmune Disease Diagnosis Market, By Disease

9 Autoimmune Disease Diagnosis Market, By End User

10 Autoimmune Disease Diagnosis Market, By Region

11 Competitive Landscape

12 Company Profiles

• Abbott
• Bio-Rad Laboratories
• Danaher
• Euroimmun
• GRIFOLS
• HYCOR Biomedical
• Inova Diagnostics
• Protagen
• Siemens
• Thermo Fisher Scientific
• Trinity Biotech

For more information about this report visit https://www.researchandmarkets.com/research/n3tznw/autoimmune?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Immune Disorders Drugs